Herpes News and Research

RSS
Herpes is an infection caused by two different but closely related viruses — herpes simplex virus type 1 (HSV-1) or cold sores and herpes simplex virus type 2 (HSV-2) or genital herpes. Both are easy to catch. They have similar symptoms (blisters or sores) and both can occur on different parts of the body. When the infection is on the mouth, it is called oral herpes. When it is on or near the sex organs, it is called genital herpes. There is no cure for herpes. Treatments are available to speed up the healing of the genital sores.
Study shows how herpes viruses and tumors have learned to manipulate the same ancient RNA

Study shows how herpes viruses and tumors have learned to manipulate the same ancient RNA

Schizophrenia patients have higher levels of antibodies against Epstein-Barr virus, study shows

Schizophrenia patients have higher levels of antibodies against Epstein-Barr virus, study shows

Sexual function in women with vulva pain improved with oral nerve pain medication

Sexual function in women with vulva pain improved with oral nerve pain medication

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Cancer patients have greater risk of developing shingles, study shows

Cancer patients have greater risk of developing shingles, study shows

New research explains how large virus shells are formed

New research explains how large virus shells are formed

NHS comes up with a list of 20 most painful conditions

NHS comes up with a list of 20 most painful conditions

Newer vaccine far more successful in preventing shingles, systematic review reveals

Newer vaccine far more successful in preventing shingles, systematic review reveals

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Could we prevent Alzheimer's disease by treating herpes?

Could we prevent Alzheimer's disease by treating herpes?

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

Researchers develop new techniques for faster detection of Lyme disease bacteria

Researchers develop new techniques for faster detection of Lyme disease bacteria

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Women with undiagnosed STIs may be at greater risk of negative premenstrual symptoms

Women with undiagnosed STIs may be at greater risk of negative premenstrual symptoms

Mechanical properties of viral DNA influence the course of infection, study finds

Mechanical properties of viral DNA influence the course of infection, study finds